Core Viewpoint - Xintian Pharmaceutical Co., Ltd. has approved a proposal to utilize part of its idle raised funds and self-owned funds for cash management, aiming to enhance the efficiency of idle fund usage without affecting normal operations or project construction [1][2]. Group 1: Board Meeting Details - The sixth board meeting was held on February 26, 2026, with all 9 directors present, and was chaired by Chairman Xie Jianzhong [1]. - The meeting's procedures complied with relevant regulations, including the Company Law and Securities Law [1]. Group 2: Cash Management Proposal - The board believes that using idle raised funds and self-owned funds for cash management will improve fund efficiency while ensuring the safety of funds and not altering the intended use of raised funds [1]. - The proposal was passed unanimously with 9 votes in favor, and no votes against or abstentions [1]. Group 3: Market Analysis - Market analysts suggest that this move will help Xintian Pharmaceutical to activate its existing funds while enhancing financial returns, reflecting a refined approach to fund management [2].
新天地药业董事会通过闲置资金现金管理追认议案 提升资金使用效率